A detailed history of Strategy Asset Managers LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Strategy Asset Managers LLC holds 6,838 shares of LLY stock, worth $5.6 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares
6,838
Previous 15,396 55.59%
Holding current value
$5.6 Million
Previous $12 Million 48.32%
% of portfolio
1.22%
Previous 2.57%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$724.87 - $909.04 $6.2 Million - $7.78 Million
-8,558 Reduced 55.59%
6,838 $6.19 Million
Q1 2024

Apr 25, 2024

BUY
$592.2 - $792.28 $158,117 - $211,538
267 Added 1.76%
15,396 $12 Million
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $4.67 Million - $5.5 Million
8,883 Added 142.22%
15,129 $8.82 Million
Q3 2023

Nov 09, 2023

SELL
$434.7 - $599.3 $257,342 - $354,785
-592 Reduced 8.66%
6,246 $3.35 Million
Q2 2023

Aug 24, 2023

BUY
$350.74 - $468.98 $13,678 - $18,290
39 Added 0.57%
6,838 $3.21 Million
Q1 2023

May 02, 2023

BUY
$310.63 - $364.82 $5,901 - $6,931
19 Added 0.28%
6,799 $2.33 Million
Q4 2022

Jan 13, 2023

SELL
$321.55 - $374.67 $26,045 - $30,348
-81 Reduced 1.18%
6,780 $2.48 Million
Q3 2022

Oct 11, 2022

BUY
$296.48 - $337.87 $791,305 - $901,775
2,669 Added 63.67%
6,861 $2.22 Million
Q2 2022

Jul 13, 2022

SELL
$278.73 - $327.27 $2,229 - $2,618
-8 Reduced 0.19%
4,192 $1.36 Million
Q1 2022

Apr 11, 2022

BUY
$234.69 - $291.66 $160,997 - $200,078
686 Added 19.52%
4,200 $1.2 Million
Q4 2021

Jan 14, 2022

SELL
$224.85 - $279.04 $154,247 - $191,421
-686 Reduced 16.33%
3,514 $971,000
Q3 2021

Dec 14, 2021

BUY
$221.6 - $272.71 $152,017 - $187,079
686 Added 19.52%
4,200 $970,000
Q2 2021

Aug 04, 2021

SELL
$180.55 - $233.54 $265,408 - $343,303
-1,470 Reduced 29.49%
3,514 $807,000
Q1 2021

May 12, 2021

SELL
$164.32 - $212.72 $580,871 - $751,965
-3,535 Reduced 41.5%
4,984 $931,000
Q4 2020

Feb 10, 2021

SELL
$130.46 - $172.63 $112,326 - $148,634
-861 Reduced 9.18%
8,519 $1.44 Million
Q3 2020

Nov 03, 2020

BUY
$146.22 - $169.13 $584,002 - $675,505
3,994 Added 74.16%
9,380 $1.39 Million
Q2 2020

Aug 10, 2020

BUY
$136.42 - $164.18 $54,295 - $65,343
398 Added 7.98%
5,386 $884,000
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $595,964 - $737,634
-5,006 Reduced 50.09%
4,988 $692,000
Q4 2019

Feb 13, 2020

BUY
$106.92 - $132.43 $104,995 - $130,046
982 Added 10.9%
9,994 $1.31 Million
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $26,590 - $28,923
249 Added 2.84%
9,012 $1.01 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $1.45 Million - $1.7 Million
-13,118 Reduced 59.95%
8,763 $971,000
Q1 2019

May 08, 2019

BUY
$111.31 - $131.02 $2.12 Million - $2.5 Million
19,072 Added 678.96%
21,881 $2.84 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $13,767 - $15,423
130 Added 4.85%
2,809 $325,000
Q2 2018

Aug 07, 2018

BUY
$75.7 - $86.88 $202,800 - $232,751
2,679 New
2,679 $229,000
Q1 2018

May 03, 2018

SELL
$74.21 - $87.6 $198,808 - $234,680
-2,679 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
2,679
2,679 $220,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Strategy Asset Managers LLC Portfolio

Follow Strategy Asset Managers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategy Asset Managers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategy Asset Managers LLC with notifications on news.